188 related articles for article (PubMed ID: 26054932)
1. Design and characterization of a new peptide vector for short interfering RNA delivery.
Chen B; Xu W; Pan R; Chen P
J Nanobiotechnology; 2015 Jun; 13():39. PubMed ID: 26054932
[TBL] [Abstract][Full Text] [Related]
2. A new amphipathic, amino-acid-pairing (AAP) peptide as siRNA delivery carrier: physicochemical characterization and in vitro uptake.
Jafari M; Xu W; Naahidi S; Chen B; Chen P
J Phys Chem B; 2012 Nov; 116(44):13183-91. PubMed ID: 23077976
[TBL] [Abstract][Full Text] [Related]
3. Characterization and evaluation of a peptide-based siRNA delivery system in vitro.
Chen B; Yoo K; Xu W; Pan R; Han XX; Chen P
Drug Deliv Transl Res; 2017 Aug; 7(4):507-515. PubMed ID: 28349343
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
Mo RH; Zaro JL; Shen WC
Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
[TBL] [Abstract][Full Text] [Related]
5. Impact of Peptide Sequence on Functional siRNA Delivery and Gene Knockdown with Cyclic Amphipathic Peptide Delivery Agents.
Jagrosse ML; Baliga UK; Jones CW; Russell JJ; García CI; Najar RA; Rahman A; Dean DA; Nilsson BL
Mol Pharm; 2023 Dec; 20(12):6090-6103. PubMed ID: 37963105
[TBL] [Abstract][Full Text] [Related]
6. Serum stability and physicochemical characterization of a novel amphipathic peptide C6M1 for siRNA delivery.
Jafari M; Xu W; Pan R; Sweeting CM; Karunaratne DN; Chen P
PLoS One; 2014; 9(5):e97797. PubMed ID: 24831131
[TBL] [Abstract][Full Text] [Related]
7. Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.
Chu D; Xu W; Pan R; Ding Y; Sui W; Chen P
Nanomedicine; 2015 Feb; 11(2):435-46. PubMed ID: 25193363
[TBL] [Abstract][Full Text] [Related]
8. siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cells.
Furukawa K; Tanaka M; Oba M
Bioorg Med Chem; 2020 Apr; 28(8):115402. PubMed ID: 32146061
[TBL] [Abstract][Full Text] [Related]
9. Modification of a designed amphipathic cell-penetrating peptide and its effect on solubility, secondary structure, and uptake efficiency.
Jafari M; Karunaratne DN; Sweeting CM; Chen P
Biochemistry; 2013 May; 52(20):3428-35. PubMed ID: 23614788
[TBL] [Abstract][Full Text] [Related]
10. Direct translocation as major cellular uptake for CADY self-assembling peptide-based nanoparticles.
Rydström A; Deshayes S; Konate K; Crombez L; Padari K; Boukhaddaoui H; Aldrian G; Pooga M; Divita G
PLoS One; 2011; 6(10):e25924. PubMed ID: 21998722
[TBL] [Abstract][Full Text] [Related]
11. Insight into the role of physicochemical parameters in a novel series of amphipathic peptides for efficient DNA delivery.
Sharma R; Shivpuri S; Anand A; Kulshreshtha A; Ganguli M
Mol Pharm; 2013 Jul; 10(7):2588-600. PubMed ID: 23725377
[TBL] [Abstract][Full Text] [Related]
12. Six-cell penetrating peptide-based fusion proteins for siRNA delivery.
Li H; Tsui T
Drug Deliv; 2015 May; 22(3):436-43. PubMed ID: 24491156
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous membrane interaction of amphipathic peptide monomers, self-aggregates and cargo complexes detected by fluorescence correlation spectroscopy.
Vasconcelos L; Lehto T; Madani F; Radoi V; Hällbrink M; Vukojević V; Langel Ü
Biochim Biophys Acta Biomembr; 2018 Feb; 1860(2):491-504. PubMed ID: 28962904
[TBL] [Abstract][Full Text] [Related]
14. Comparative characterization and cytotoxicity study of TAT-peptide as potential vectors for siRNA and Dicer-substrate siRNA.
Katas H; Abdul Ghafoor Raja M; Ee LC
Drug Dev Ind Pharm; 2014 Nov; 40(11):1443-50. PubMed ID: 23962166
[TBL] [Abstract][Full Text] [Related]
15. Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.
Xiang B; Jia XL; Qi JL; Yang LP; Sun WH; Yan X; Yang SK; Cao DY; Du Q; Qi XR
Int J Nanomedicine; 2017; 12():2385-2405. PubMed ID: 28405163
[TBL] [Abstract][Full Text] [Related]
16. Modeling of non-covalent complexes of the cell-penetrating peptide CADY and its siRNA cargo.
Crowet JM; Lins L; Deshayes S; Divita G; Morris M; Brasseur R; Thomas A
Biochim Biophys Acta; 2013 Feb; 1828(2):499-509. PubMed ID: 23000699
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable nanoparticles of mPEG-PLGA-PLL triblock copolymers as novel non-viral vectors for improving siRNA delivery and gene silencing.
Du J; Sun Y; Shi QS; Liu PF; Zhu MJ; Wang CH; Du LF; Duan YR
Int J Mol Sci; 2012; 13(1):516-533. PubMed ID: 22312268
[TBL] [Abstract][Full Text] [Related]
18. A myristoylated cell-penetrating peptide bearing a transferrin receptor-targeting sequence for neuro-targeted siRNA delivery.
Youn P; Chen Y; Furgeson DY
Mol Pharm; 2014 Feb; 11(2):486-95. PubMed ID: 24387132
[TBL] [Abstract][Full Text] [Related]
19. A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells.
Crombez L; Aldrian-Herrada G; Konate K; Nguyen QN; McMaster GK; Brasseur R; Heitz F; Divita G
Mol Ther; 2009 Jan; 17(1):95-103. PubMed ID: 18957965
[TBL] [Abstract][Full Text] [Related]
20. Uptake Mechanism and Direct Translocation of a New CPP for siRNA Delivery.
Pan R; Xu W; Ding Y; Lu S; Chen P
Mol Pharm; 2016 Apr; 13(4):1366-74. PubMed ID: 26937821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
